Cerebrospinal fluid biomarkers of efficacy in patients affected by spinal muscular atrophy type 1 treated with nusinersen

Related articles

1. A Multi-Modal Framework Combining Proteomics, Electrophysiology, and Clinical Phenotypes to Characterize Neuroplasticity in Parkinson’s Disease Rehabilitation

   This article has 1 author:

   1. Jingyuan Lin

2. Associations of Inflammatory Biomarkers with Brain Atrophy and Clinical Scores in Schizophrenia Patients with Autistic Features

   This article has 7 authors:

   1. Jin Wang
   2. Jie Shen
   3. Yu Pang
   4. Jihui Liu
   5. Lili Zhao
   6. Momo Sun
   7. Yang Yang

3. Uncoupling of CSF biomarkers and clinical status in patients with a novel mutation of ATP13a2

   This article has 21 authors:

   1. C Stephani
   2. D Ewers
   3. D Stausberg
   4. D Rasche
   5. A Bahiraee
   6. B Ahmad
   7. M Bähr
   8. B Downie
   9. S Hirschel
   10. S Pauli
   11. C Riedel
   12. A Sachkova
   13. G Salinas
   14. A Schneider
   15. C van Riesen
   16. B Wollnik
   17. G Yigit
   18. KA Nave
   19. I Zerr
   20. S Eggert
   21. MW Sereda